Advertisement
Screener

MACROGENICS, INC. (MGNX) Lessee, Operating Lease, Liability, Undiscounted Excess Amount

2.8 / 5 stars · 68/120 Roast Me

MACROGENICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount

MACROGENICS, INC. (MGNX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $28.54 million as of 2025-12-31, per its 10-K filed 2026-03-09.

Financial Statements › Notes › Leases

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-09

  • 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28.54M.
  • 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33.02M.
  • 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $36.31M.
  • 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $40.44M.
Period endLessee, Operating Lease, Liability, Undiscounted Excess Amount
2025-12-31$28.54M
10-K · filed 2026-03-09
2024-12-31$33.02M
10-K · filed 2025-03-20
2023-12-31$36.31M
10-K · filed 2024-03-07
2022-12-31$40.44M
10-K · filed 2023-03-15
2021-12-31$6.97M
10-K · filed 2022-02-24
2020-12-31$9.92M
10-K · filed 2021-02-25
2019-12-31$11.73M
10-K · filed 2020-02-25
2019-09-30$12.55M
10-Q · filed 2019-11-06
2019-06-30$11.28M
10-Q · filed 2019-07-31
2019-03-31$12.10M
10-Q · filed 2019-05-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35